BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9315097)

  • 1. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of cyclin D1 enhances gene amplification.
    Zhou P; Jiang W; Weghorst CM; Weinstein IB
    Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-myc overexpression and p53 loss cooperate to promote genomic instability.
    Yin XY; Grove L; Datta NS; Long MW; Prochownik EV
    Oncogene; 1999 Feb; 18(5):1177-84. PubMed ID: 10022123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM; Farnham PJ
    Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a phylogenetically conserved Sug1 CAD family member that is differentially expressed in the mouse nervous system.
    Sun D; Swaffield JC; Johnston SA; Milligan CE; Zoeller RT; Schwartz LM
    J Neurobiol; 1997 Dec; 33(7):877-90. PubMed ID: 9407011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
    Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
    Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines.
    Mai S; Hanley-Hyde J; Fluri M
    Oncogene; 1996 Jan; 12(2):277-88. PubMed ID: 8570205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene amplification].
    Taira M; Koike K
    Tanpakushitsu Kakusan Koso; 1984 Mar; 29(3):152-63. PubMed ID: 6425988
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG; Goldsworthy TL; Cattley RC
    Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
    Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
    Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras.
    Chen CY; Liou J; Forman LW; Faller DV
    Cell Death Differ; 1998 Nov; 5(11):984-95. PubMed ID: 9846185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the Chinese hamster CAD gene reveals homology between human chromosome 2p and Chinese hamster 7q.
    Bertoni L; Attolini C; Simi S; Giulotto E
    Genomics; 1993 Jun; 16(3):779-81. PubMed ID: 8100805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA transfection into mammalian cells, selective markers and gene cointegration.
    Colbère-Garapin F; Ryhiner ML; Garapin AC
    Dev Biol Stand; 1989; 70():85-9. PubMed ID: 2569429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.
    Hsu B; Marin MC; el-Naggar AK; Stephens LC; Brisbay S; McDonnell TJ
    Oncogene; 1995 Jul; 11(1):175-9. PubMed ID: 7624125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.